As more women turn to genetic testing for breast cancer, understanding risk is key – Washington Post
Washington Post |
As more women turn to genetic testing for breast cancer, understanding risk is key
Washington Post The Food and Drug Administration not long ago announced its authorization that permits genetics testing company 23andMe to market a test for gene mutations associated with risk of breast and ovarian cancer. In response, 23andMe CEO Anne Wojcicki … Is 23andMe's Test For Breast Cancer Gene Mutation Good For Jewish Women? |